Business Context and Reporting Period
This Form 8-K filing by Bio-Rad Laboratories, Inc. was submitted on October 26, 2011, with a signature date of November 1, 2011. The report primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on personnel appointments rather than financial performance data.
Material Changes
The material change reported is the appointment of Deborah J. Neff to the Board of Directors on October 26, 2011. Ms. Neff is scheduled to stand for election at the 2012 annual meeting of stockholders. The filing explicitly states there is no arrangement or understanding pursuant to which she was appointed.
Compensation and Governance Details
Ms. Neff's compensation is aligned with other non-employee directors and includes:
- A monthly fee of $4,167.
- An additional $100 per Board meeting for any meetings in excess of 16 per year.
The filing references a press release dated November 1, 2011, as Exhibit 99.1, but the content of that release is not included in the provided text.
Investor Verification Checklist
- Verify the full text of the November 1, 2011 press release (Exhibit 99.1) for any additional context regarding the appointment.
- Confirm Ms. Neff's professional background and qualifications via the company's proxy statement for the 2012 annual meeting.
- Review the company's most recent 10-Q or 10-K filing for actual financial performance metrics, as this 8-K does not contain them.